Dr. Sudarshan K. Sharma, Ltd.

Hinsdale, Illinois 60521

1 studies enrolling now · 4 studies all time

What they study most

Endometrial Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Platinum-resistant Ovarian Cancer, Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line

Studies at this site

• Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer — Recruiting now
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
• Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer — Stopped early
• Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer — Completed